13F Filings History of MIROVA

Latest 13F report
Q4 2025 - 13 Feb 2026
Value $
$693,520,702
Signature - Title
Violaine Olivier Mainguy - CHIEF COMPLIANCE OFFICER
Location
Paris, France
Summary
This page shows a list of all the recent 13F filings made by MIROVA. Form 13F is required to be filed within 45 days of the end of a calendar quarter. MIROVA reported 92 stock holdings with total value $693,520,702 as of Q4 2025. Top holdings included NVDA, MSFT, ECL, ACN, and FSLR.

Notify me when MIROVA files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value

List of Other Managers Reporting for MIROVA:

Name Holdings Value Location File Number
Mirova US LLC $9,960,349,006 Boston, MA 028-20101
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 92 $693,520,702 +$49,347,940 -$62,809,176 -$13,461,236 NVDA, MSFT, ECL, ACN, FSLR 13F-HR 13 Feb 2026, 16:05
Q3 2025 111 $707,434,117 +$71,179,733 -$94,775,913 -$23,596,180 NVDA, MSFT, ECL, ACN, FSLR 13F-HR 29 Dec 2025, 12:17
Q2 2025 119 $708,801,500 +$147,677,889 -$27,703,948 +$119,973,941 TMO, ECL, NVDA, MSFT, ACN 13F-HR 13 Aug 2025, 16:06
Q1 2025 134 $555,884,538 +$21,576,716 -$17,851,844 +$3,724,872 TMO, ECL, ACN, NVDA, MSFT 13F-HR 14 May 2025, 16:04
Q4 2024 129 $579,516,713 +$67,693,423 -$33,819,514 +$33,873,909 TMO, ACN, ECL, NVDA, MSFT 13F-HR 13 Feb 2025, 16:08
Q3 2024 120 $578,678,314 +$28,808,104 -$33,651,823 -$4,843,719 TMO, ACN, ECL, NVDA, MSFT 13F-HR 13 Nov 2024, 16:09
Q2 2024 123 $547,265,530 +$72,467,632 -$53,546,703 +$18,920,929 TMO, ACN, ECL, NVDA, MSFT 13F-HR 13 Aug 2024, 16:01
Q1 2024 135 $564,513,157 +$118,280,689 -$75,970,674 +$42,310,015 TMO, ACN, ECL, NVDA, MSFT 13F-HR 13 May 2024, 16:00
Q4 2023 126 $488,247,352 +$26,343,513 -$94,820,326 -$68,476,813 TMO, ACN, ECL, GIB, ENPH 13F-HR 13 Feb 2024, 16:00
Q3 2023 126 $496,642,740 +$35,374,334 -$52,257,375 -$16,883,041 TMO, ACN, ENPH, GIB, ECL 13F-HR 14 Nov 2023, 06:42
Q2 2023 163 $568,143,412 +$17,483,136 -$148,330,518 -$130,847,382 TMO, ENPH, ACN, RUN, ECL 13F-HR 11 Aug 2023, 16:11
Q1 2023 164 $693,319,652 +$135,665,804 -$110,089,150 +$25,576,654 TMO, ECL, ENPH, RUN, ACN 13F-HR 12 May 2023, 16:01
Q4 2022 181 $638,758,172 +$50,813,554 -$39,838,794 +$10,974,760 TMO, ECL, RUN, GIB, MSFT 13F-HR 13 Feb 2023, 16:48
Q3 2022 171 $594,320,000 +$50,259,670 -$129,855,100 -$79,595,430 TMO, ECL, RUN, GIB, MSFT 13F-HR 14 Nov 2022, 11:03
Q2 2022 171 $703,657,000 +$99,454,811 -$39,386,724 +$60,068,087 TMO, ECL, RUN, MSFT, GIB 13F-HR 12 Aug 2022, 16:20
Q1 2022 174 $747,078,000 +$96,713,079 -$90,098,395 +$6,614,684 TMO, ECL, RUN, MSFT, GIB 13F-HR 13 May 2022, 16:00
Q4 2021 172 $835,110,000 +$122,286,116 -$106,001,944 +$16,284,172 TMO, ECL, RUN, BLDP, WOLF 13F-HR 14 Feb 2022, 12:19
Q3 2021 165 $777,136,000 +$36,289,230 -$65,152,168 -$28,862,938 TMO, ECL, RUN, BLDP, CREE 13F-HR 12 Nov 2021, 16:02
Q2 2021 165 $834,225,000 +$28,589,060 -$43,381,281 -$14,792,221 TMO, ECL, RUN, BLDP, FSLR 13F-HR 13 Aug 2021, 13:18
Q1 2021 164 $838,103,000 +$174,661,260 -$100,163,918 +$74,497,342 TMO, ECL, RUN, BLDP, FSLR 13F-HR 14 May 2021, 10:53
Q4 2020 163 $777,684,000 +$181,863,350 -$127,078,523 +$54,784,827 ECL, TMO, ITRI, BLDP, RUN 13F-HR 12 Feb 2021, 12:57
Q3 2020 195 $621,246,000 +$137,191,703 -$148,816,043 -$11,624,340 TMO, ECL, VSLR, ITRI, DHR 13F-HR 12 Nov 2020, 16:01
Q2 2020 175 $435,562,000 +$107,836,195 -$7,157,767 +$100,678,428 TMO, ECL, DHR, VSLR, FSLR 13F-HR 13 Aug 2020, 09:35
Q1 2020 173 $264,238,000 +$57,559,957 -$32,395,065 +$25,164,892 TMO, ECL, FSLR, DHR, GIB 13F-HR 14 May 2020, 14:59
Q4 2019 177 $287,350,000 +$29,266,719 -$605,072,434 -$575,805,715 TMO, ECL, DHR, FSLR, GIB 13F-HR 14 Feb 2020, 08:33
Q3 2019 127 $810,998,000 +$12,672,106 -$355,104,274 -$342,432,168 TMO, ECL, DHR, MSFT, MA 13F-HR 13 Nov 2019, 13:19
Q2 2019 129 $1,131,463,000 +$936,788,242 -$3,201,670 +$933,586,572 TMO, ECL, DHR, MA, MSFT 13F-HR 13 Aug 2019, 09:06
Q1 2019 99 $184,372,000 +$26,256,639 -$95,554,456 -$69,297,817 TMO, ECL, GIB, DHR, NVDA 13F-HR 15 May 2019, 08:31
Q4 2018 95 $218,744,000 $0 $0 $0 TMO, ECL, DHR, GIB, CRTO 13F-HR 14 Feb 2019, 12:57